Roxbury Financial’s Fidelity Blue Chip Growth ETF FBCG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.18M Sell
81,989
-12
-0% -$739 3.98% 3
2026
Q2
$5.09M Buy
82,001
+681
+0.8% +$40.4K 4.03% 3
2026
Q1
$4.08M Buy
81,320
+142
+0.2% +$7.55K 3.66% 3
2025
Q4
$4.45M Sell
81,178
-4,106
-5% -$223K 3.99% 3
2025
Q3
$4.58M Sell
85,284
-5,230
-6% -$266K 4.23% 2
2025
Q2
$4.37M Buy
90,514
+2,974
+3% +$127K 4.25% 2
2025
Q1
$3.93M Buy
87,540
+5,857
+7% +$265K 3.85% 2
2024
Q4
$3.76M Buy
+81,683
New +$3.7M 3.62% 2

Other funds holding FBCG

Roxbury Financial's FBCG Position: Q3 2026 in Review

Roxbury Financial reduced its Fidelity Blue Chip Growth ETF (FBCG) stake by 0.01% in Q3 2026, selling an estimated $739 and leaving 81,989 shares worth $5.18M. The position accounts for 3.98% of the portfolio, ranked #3.

Roxbury Financial first reported a position in FBCG in Q4 2024 and has held it in 8 quarters since. 21 funds tracked by Wall St. Rank hold FBCG as of Q3 2026.

  • Roxbury Financial held 81,989 shares of Fidelity Blue Chip Growth ETF worth $5.18M as of Q3 2026.
  • Roxbury Financial sold 12 Fidelity Blue Chip Growth ETF shares in Q3 2026, an estimated $739.
  • Fidelity Blue Chip Growth ETF made up 3.98% of Roxbury Financial's portfolio in Q3 2026, its #3 holding.
  • Roxbury Financial first reported a position in Fidelity Blue Chip Growth ETF in Q4 2024 and has held it in 8 quarters since.
  • 21 funds tracked by Wall St. Rank held Fidelity Blue Chip Growth ETF as of Q3 2026.

Based on Roxbury Financial's 13F filing for Q3 2026, filed 1 Oct 2026.